The short answer
Folic acid can be appropriate when needed, but starting or changing it during phenobarbital treatment deserves review. An older controlled study found lower phenobarbital levels without a statistically significant worsening of seizures.
What this answer covers
Exact folic acid replacement; dietary folate, folinic acid and methylfolate are distinct exposures.
- Supplement or preparation
- Folic acid
- Medication ingredient
- phenobarbital
Balance treatment of deficiency with seizure control
Do not leave a diagnosed deficiency untreated because of an interaction warning. Ask the prescriber to coordinate folic acid treatment with your antiseizure care.
Separate blood levels from clinical outcomes
In the controlled folic acid study, phenobarbital concentrations decreased but seizure frequency and severity did not change significantly. This supports monitoring rather than assuming folic acid always makes treatment fail.
Do not assume every vitamin problem is folate
A large cohort associated phenobarbital with lower B12, while other drugs were associated with lower folate. Symptoms or abnormal blood counts need appropriate assessment, not an automatic folic acid prescription.
Keep the prescribed medicine steady
Do not stop phenobarbital abruptly or adjust its dose to compensate for a supplement. Sudden withdrawal can provoke serious seizures. Tell the prescriber about new or worsening symptoms and all supplement changes.
Evidence and practical considerations
Timing & monitoring
Conditional nutrition and drug-level review is supported; lower drug concentrations are not proof of impaired absorption or inevitable seizure worsening.
- Exact scope
- Exact folic acid replacement; dietary folate, folinic acid and methylfolate are distinct exposures. with Exact oral phenobarbital; parent and metabolites distinguished; no other drug/route assumed equivalent.
- Medication form and route
- oral supplement unless pregnancy section explicitly distinguishes neonatal injection
- Timing or duration
- Preparation, dose and duration determine applicability; chronic nutrition evidence is not a single-dose interaction.
What remains uncertain
- Old trial, abstract-only detail and mixed therapies. The large cohort named phenobarbital for lower B12 rather than lower folate; universal folate depletion is not established.
Factors that may matter: exact supplement identity; dose; other medicines; clinical indication; baseline nutrition; pregnancy where relevant.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral phenobarbital.
Causes CNS depression and can impair driving; other CNS depressants can add to these effects. Adult plasma half-life is prolonged. Abrupt withdrawal after dependence can cause seizures and other serious symptoms. Long-term treatment warrants periodic clinical and laboratory assessment.
How this applies: Exact RxCUI 8134 IN and UNII YQE403BP4D, oral plain ingredient; no automatic sodium-injection or other barbiturate transfer.
Does not name the requested botanicals or establish supplement-specific interaction rates or spacing. Current DailyMed listing is unapproved drug other, not evidence of FDA approval.
Source 2: original clinical research
jamanetwork.com · Source check Sep 10, 2026
Population: Epilepsy patients with low serum and CSF folate.
Serum/CSF phenobarbital concentrations decreased, but seizure frequency and severity did not change statistically.
How this applies: Apply only to the named drugs and study exposures; no unmeasured parent/metabolite or preparation equivalence.
Original publisher abstract inspected through web reader; full text not obtained. Folic acid dose, exact monotherapy contribution and individual outcomes are not resolved. Does not prove reduced intestinal absorption.
Source 3: original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 2730 treated and 170 untreated epilepsy patients plus 200 healthy controls.
Primidone was among drugs associated with lower folate; phenobarbital was named for lower B12, not lower folate, in the abstract. Replacement corrected vitamin values in most deficient patients.
How this applies: Apply only to the named drugs and study exposures; no unmeasured parent/metabolite or preparation equivalence.
Observational and mixed-treatment results; not proof that phenobarbital lowers folate in every user or that every primidone user needs a supplement. Biochemical improvement is not proof of seizure or cognitive benefit.
Source 4: original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 72 people on long-term phenytoin, alone or with phenobarbital.
Folate did not improve measured neuropsychological outcomes; thiamine improved some measures.
How this applies: Apply only to the named drugs and study exposures; no unmeasured parent/metabolite or preparation equivalence.
Mixed phenytoin-based treatment; no phenobarbital-only estimate. Does not negate indicated treatment of a diagnosed folate deficiency.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Exact current available claims reviewed against captured originals; no clinical review asserted. | |
| Research summary published |
Article revision: 61540a1b93db71d6
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.